Mark N. Lampert, 10% Owner at Xenon Pharmaceuticals Inc. (XENE), bought 20,411 shares at $4.00 ($82K) on 2017-06-22, disclosed to the SEC on 2017-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.00 | 1,362 | $5K | 6.7% |
| 2 | $4.00 | 4,406 | $18K | 21.6% |
| 3 | $4.00 | 6,380 | $26K | 31.3% |
| 4 | $4.00 | 854 | $3K | 4.2% |
| 5 | $4.00 | 2,884 | $12K | 14.1% |
| 6 | $4.00 | 4,525 |
| $18K |
| 22.2% |
| Total | $4.00 avg | 20,411 | $82K | 100% |
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |